Raafat, Nermin and Mosaad, Hala and Emam, Wafaa and Galal, Sherif M. and El-Gerby, Khaled M. and Elnaggar, Yasser (2015) Possible Relationship between Matrix Metalloproteinases Genotyping and Risk of Hepatocellular Carcinoma in HCV Infected Patients. International Journal of Biochemistry Research & Review, 8 (3). pp. 1-11. ISSN 2231086X
Raafat832015IJBCRR20013.pdf - Published Version
Download (261kB)
Abstract
Background: The annual number of new cases of hepatocellular carcinoma (HCC) worldwide is over 1 million. In developing countries, the major cause of HCC is chronic hepatitis C virus (HCV) infection. Various studies have reported an association between functional gene polymorphism of matrix metalloproteinases (MMP) promoters and different cancers.
Rationale: This study examined the association between MMP1 -1607, MMP9-1562, MMP14-6727 and MMP14-6767 gene polymorphisms and risk of HCC in HCV infected patients.
Methods: The study enrolled 160 HCC patients, 91 with & 69 without chronic HCV infection, and 140 healthy subjects as control group. Genomic DNA was analysed for MMPs gene polymorphism using restriction fragment length polymorphism polymerase chain reaction (RFLP-PCR) for MMP1 and MMP9 but real time PCR was used for MMP14 genotyping.
Results: MMP1-2G allele carriers had higher susceptibility of developing HCC in HCV infected patients. MMP9-1562 T/T genotype had high risk of developing HCC in HCV and non HCV related patients when compared to healthy controls. A significant lower risk for HCC was shown in individuals with MMP14-6767 G/A. The distribution frequency of MMP14-6767 G and MMP14-6727 C allele and homozygote genotype was significantly higher in HCC patients.
Conclusion: MMP-1 -1607 2G allele carriers would alter the risk of HCC under specific conditions such as chronic infection with HCV. People with MMP9-1562 T/T genotype are at risk of developing HCC. MMP14-6767 G and MMP14-6727 C allele carriers and homozygote genotype might contribute to the prediction of susceptibility and pathological development of HCC in HCV infected patients.
Item Type: | Article |
---|---|
Subjects: | Research Scholar Guardian > Biological Science |
Depositing User: | Unnamed user with email support@scholarguardian.com |
Date Deposited: | 15 Jul 2023 06:03 |
Last Modified: | 27 Jan 2024 04:01 |
URI: | http://science.sdpublishers.org/id/eprint/1007 |